These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37405210)

  • 1. A Case of Tracheoesophageal Fistula in a Non-metastatic Site During Lenvatinib Treatment for Hepatocellular Carcinoma.
    Yokota K; Kitagawa H; Okamoto K; Namikawa T; Maeda H; Kobayashi M; Seo S
    Cancer Diagn Progn; 2023; 3(4):475-478. PubMed ID: 37405210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series.
    Ichimura T; Ichikura D; Hinata M; Hida N; Baba T
    SAGE Open Med Case Rep; 2023; 11():2050313X231164488. PubMed ID: 37009547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of rapid progression of esophageal varices after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.
    Furusawa A; Naganuma A; Suzuki Y; Hoshino T; Yasuoka H; Tamura Y; Naruse H; Hatanaka T; Kakizaki S
    Clin J Gastroenterol; 2022 Apr; 15(2):451-459. PubMed ID: 35179703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
    Persano M; Rimini M; Tada T; Suda G; Shimose S; Kudo M; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Yoo C; Lonardi S; Tovoli F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Niizeki T; Montes M; Vivaldi C; Soldà C; Stefanini B; Hiraoka A; Sho T; Nishida N; Steup C; Iavarone M; Di Costanzo G; Marra F; Tamburini E; Cabibbo G; Foschi FG; Silletta M; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Campani C; Amadeo E; Rossari F; Burgio V; Cascinu S; Scartozzi M; Casadei-Gardini A
    Eur J Cancer; 2023 Aug; 189():112933. PubMed ID: 37385069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired Tracheoesophageal Fistula through Esophageal Diverticulum in Patient Who Had a Prolonged Tracheostomy Tube - A Case Report -.
    Jung JH; Kim JS; Kim YK
    Ann Rehabil Med; 2011 Jun; 35(3):436-40. PubMed ID: 22506156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of preoperative 3D CT reconstruction for evaluation of patients with esophageal atresia and tracheoesophageal fistula.
    Mahalik SK; Sodhi KS; Narasimhan KL; Rao KL
    Pediatr Surg Int; 2012 Oct; 28(10):961-6. PubMed ID: 22722826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.
    Toda S; Kadoya M; Matsui A; Murayama D; Iwasaki H
    Ann Palliat Med; 2022 Nov; 11(11):3571-3577. PubMed ID: 35726194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma.
    Komatsu S; Yano Y; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yamamoto A; Goto T; Yanagimoto H; Toyama H; Ueda Y; Kodama Y; Fukumoto T
    Anticancer Res; 2022 Nov; 42(11):5479-5486. PubMed ID: 36288850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report.
    Yokoo H; Takahashi H; Hagiwara M; Iwata H; Imai K; Saito Y; Matsuno N; Furukawa H
    World J Hepatol; 2020 Dec; 12(12):1349-1357. PubMed ID: 33442460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Han Y; Zhi WH; Xu F; Zhang CB; Huang XQ; Luo JF
    World J Gastroenterol; 2021 May; 27(19):2415-2433. PubMed ID: 34040331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients.
    Chen YH; Chen YY; Wang JH; Hung CH
    Anticancer Res; 2023 Mar; 43(3):1377-1384. PubMed ID: 36854513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.
    Namba M; Kawaoka T; Aikata H; Kodama K; Uchikawa S; Ohya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Chayama K
    Clin J Gastroenterol; 2019 Aug; 12(4):341-346. PubMed ID: 30706429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of preoperative CT scan in patients with tracheoesophageal fistula: a review.
    Garge S; Rao KL; Bawa M
    J Pediatr Surg; 2013 Sep; 48(9):1966-71. PubMed ID: 24074676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma.
    Su CW; Teng W; Lin PT; Jeng WJ; Chen KA; Hsieh YC; Chen WT; Ho MM; Hsieh CH; Wang CT; Chai PM; Lin CC; Lin CY; Lin SM
    Cancer Med; 2023 Mar; 12(6):7077-7089. PubMed ID: 36468578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report.
    Miwa T; Kochi T; Watanabe K; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
    J Rural Med; 2021 Apr; 16(2):102-110. PubMed ID: 33833836
    [No Abstract]   [Full Text] [Related]  

  • 16. Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma.
    Miyajima S; Tsuji K; Kito Y; Yoshida N; Matsunaga K; Tsuji S; Katayanagi K; Yonezawa M; Kubo A; Ushijima K; Minato H; Doyama H
    Clin J Gastroenterol; 2021 Feb; 14(1):187-192. PubMed ID: 33025343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
    Rimini M; Persano M; Tada T; Suda G; Shimose S; Kudo M; Cheon J; Finkelmeier F; Lim HY; Presa J; Salani F; Lonardi S; Piscaglia F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Schirripa M; Montes M; Vivaldi C; Soldà C; Hiraoka A; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Burgio V; Scartozzi M; Cascinu S; Casadei-Gardini A
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7565-7577. PubMed ID: 36976353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.
    Imakura T; Sato S; Tomonari T; Murakami K; Takahashi N; Naito N; Mima M; Kagawa K; Koyama K; Nishimura H; Kawano H; Nokihara H; Azuma M; Takayama T; Nishioka Y
    Intern Med; 2022 Apr; 61(8):1211-1217. PubMed ID: 34544944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cicatricial tracheal stenosis and tracheoesophageal fistula in patients with COVID-19 pneumonia].
    Parshin VD; Avdeev SN; Rusakov MA; Parshin AV; Ursov MA; Parshin VV; Merzhoeva ZM
    Khirurgiia (Mosk); 2023; (1):13-22. PubMed ID: 36583489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma.
    Sano S; Asahi Y; Kamiyama T; Kakisaka T; Orimo T; Nagatsu A; Aiyama T; Kazui K; Shomura H; Ueki S; Sakamoto Y; Shirakawa C; Kamachi H; Sugino H; Mitsuhashi T; Taketomi A
    Int Cancer Conf J; 2023 Jan; 12(1):7-13. PubMed ID: 36605836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.